Many studies have shown significant risk factors associated with undiagnosed and untreated sleep apnea including daytime sleepiness, hypertension, traffic accidents, diabetes, cardiovascular and cerebrovascular diseases. An aging population and obesity aggravate dramatically the prevalence of sleep apnea. Despite the increasing demand for faster diagnosis and effective treatment, there is a lack of technological advances and resources in the conventional clinical setting. The prevailing diagnostic test for sleep apnea tends to be inadequate and costly; which limits patient access to testing.
As a result, as many as 90% of people with sleep apnea could remain undiagnosed.
Reliable. easy. accessible.
Nukute combines tracheal sensor, accelerometer, pulse oximeter and secured cloud-based application into an effective solution for screening and diagnosis of Sleep Apnea. Nukute makes Apnea Hypopnea Index (AHI) measurement more comfortable, accessible and affordable.
- Ease of use in clinics and home setting
- Easy, step-by-step user guide
- Measurement of air flow via tracheal sensor and SPO2
- Can be used simultaneously with CPAP mask
- Gravity meter detects sleeping position
- Supported by our secured cloud-based application
- Customised AHI report can be downloaded after completion of test
We are collaborating with leading sleep disorder experts, university hospitals and industry partners globally to produce technologically advanced medical devices; and we are in the process of complying with medical device regulations and standards.
In 2017, Nukute was selected by the EU Horizon 2020, Framework Program for Research and Innovation 2014-2020 for SME1 and SME2 in the scope of Open Disruptive Innovation Scheme; as one of the Top 10 SMEs among 500 applicants. The Seal of excellence award is an international recognition of Nukute’s solution in medical technology.